ArticleTranslational andrology and urology2024
Evaluating the necessity of postoperative day 1 labs following laparoscopic radical nephrectomy (LRN).
Article in Translational andrology and urology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Standard postoperative care following laparoscopic radical nephrectomy (LRN) typically includes routine blood tests. Recent studies have assessed the safety of omitting routine postoperative labs in minimally invasive surgeries to reduce hospital costs. Our primary objective was to evaluate if routine postoperative day 1 (POD1) labs were necessary following LRN. Methods: We evaluated 650 consecutive LRN performed by a single surgeon. Patients on dialysis or that previously had a renal transplant were excluded from the study. Our final analysis included 478 LRN. We examined POD1 labs of potassium (K), sodium (Na), and hemoglobin (Hgb) and their associations to preoperative and postoperative outcomes. Abnormal K at POD1 was defined as less than 3.5 mEq/L or greater than 5.0 mEq/L. Abnormal Na at POD1 was defined as less than 135 mEq/L or more than 145 mEq/L. Abnormal Hgb at POD1 was defined as POD1 Hgb less than 8 g/dL or POD1 Hgb 3.0 g/dL or more decrease from preoperative Hgb. Results: One or more abnormal POD1 labs were observed in 32.4% (155/478) patients. Sixty-five patients had abnormal Hgb, 57 had abnormal Na, and 53 had abnormal K. Preoperative patient factors associated with abnormal labs included older age [odds ratio (OR) 0.461; 95% confidence interval (CI): 0.26-0.809], higher Charlson comorbidity index (CCI) (OR 1.671; 95% CI: 1.036-2.7), and increased intraoperative blood loss (OR 1.213; 95% CI: 1.069-1.39; all P<0.05). Intraoperative variables such as longer operative time and complications were not significantly associated with abnormal labs (P>0.05). Conclusions: Abnormal labs on POD1 following LRN were found in 32.4% of patients. POD1 lab tests appear to be needed following LRN in older patients with more comorbidities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.